SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Bill Wexler's Dog Pound
REFR 1.700+4.7%10:59 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dale Baker who wrote (7324)8/10/2000 4:07:49 AM
From: Bill Wexler  Read Replies (2) of 10293
 
The GUMM stock promotion fraud admits failure and adopts a new stock promotion scheme:

biz.yahoo.com

The "drug delivery technology" scam has been employed by numerous phony biotech firms. What they usually do is take an existing generic medication and propose a new "delivery technology" which they will claim magically causes the medication to work on some widespread malady. They then file an NDA which inevitably gets laughed out of the FDA, but while the clock is ticking, the stock promoters pump it and dump it. This technique was used very effectively by one of my favorite shorts: Zonagen (ZONA) and with some limited succes by another stock I shorted: Macrochem (MCHM).

Zonagen attempted to piggyback on the success of Viagra and the excitement surrounding the ED field by claiming that a 50-year old generic heart medication named phentolamine would cause erections if it was taken using Zonagen's "proprietary delivery technology"...namely, a pill you swallow. Small investors lost millions.

I strongly caution investors to think twice before buying shares of GUMM.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext